Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 150

1.

Triple therapy with boceprevir or telaprevir in a European cohort of cirrhotic HIV/HCV genotype 1-coinfected patients.

Miailhes P, Gilbert C, Lacombe K, Arends JE, Puoti M, Rockstroh JK, Sogni P, Fontaine H, Rosenthal E, Winnock M, Loko MA, Wittkop L, Dabis F, Salmon D; the ESCMID European Study Group on Viral Hepatitis.

Liver Int. 2015 Feb 4. doi: 10.1111/liv.12799. [Epub ahead of print]

PMID:
25650873
2.

Hepatitis B and human immunodeficiency virus co-infection.

Phung BC, Sogni P, Launay O.

World J Gastroenterol. 2014 Dec 14;20(46):17360-7. doi: 10.3748/wjg.v20.i46.17360.

3.

Effect of Nucleoside and Nucleotide Analogues on Renal Function in Patients With Chronic Hepatitis B Virus Monoinfection.

Mallet V, Schwarzinger M, Vallet-Pichard A, Fontaine H, Corouge M, Sogni P, Pol S.

Clin Gastroenterol Hepatol. 2014 Nov 21. pii: S1542-3565(14)01712-1. doi: 10.1016/j.cgh.2014.11.021. [Epub ahead of print]

PMID:
25460550
4.

Investigating liver stiffness and viscosity for fibrosis, steatosis and activity staging using shear wave elastography.

Deffieux T, Gennisson JL, Bousquet L, Corouge M, Cosconea S, Amroun D, Tripon S, Terris B, Mallet V, Sogni P, Tanter M, Pol S.

J Hepatol. 2015 Feb;62(2):317-24. doi: 10.1016/j.jhep.2014.09.020. Epub 2014 Sep 22.

PMID:
25251998
5.

Telaprevir for HIV/hepatitis C virus-coinfected patients failing treatment with pegylated interferon/ribavirin (ANRS HC26 TelapreVIH): an open-label, single-arm, phase 2 trial.

Cotte L, Braun J, Lascoux-Combe C, Vincent C, Valantin MA, Sogni P, Lacombe K, Neau D, Aumaitre H, Batisse D, de Truchis P, Gervais A, Michelet C, Morlat P, Vittecoq D, Rosa I, Bertucci I, Chevaliez S, Aboulker JP, Molina JM; French National Agency for Research on AIDS and Viral Hepatitis (ANRS) HC26 Study Group.

Clin Infect Dis. 2014 Dec 15;59(12):1768-76. doi: 10.1093/cid/ciu659. Epub 2014 Aug 18.

PMID:
25139963
6.

B-04: Les niveaux de LDL-cholestérol et de triglycérides sont des facteurs prédictifs indépendants d'évènements cardiovasculaires chez les patients co-infectés VIH-VHC : cohorte HEPAVIH-ANRS CO13.

Tan BK, Gilbert C, Boccara F, Morlat P, Poizot-Martin I, Sogni P, Salmon D.

Med Mal Infect. 2014 Jun;44(6 Suppl):30. doi: 10.1016/S0399-077X(14)70125-8. French. No abstract available.

PMID:
24994213
7.

COL01-04: Accès à la transplantation hépatique (TH) chez les patients (pts) coinfectés VIH-VHC de la cohorte ANRSCO13 HEPAVIH.

Poizot-Martin I, Gilbert C, Teicher E, Pialoux G, Sogni P, Wittkop L, Salmon-Ceron D.

Med Mal Infect. 2014 Jun;44(6 Suppl):2. doi: 10.1016/S0399-077X(14)70042-3. French. No abstract available.

PMID:
24994129
8.

Role of a 48-week pegylated interferon therapy in hepatitis B e antigen positive HIV-co-infected patients on cART including tenofovir: EMVIPEG study.

Miailhes P, Maynard-Muet M, Lebossé F, Carrat F, Bouix C, Lascoux-Combe C, Sogni P, Rey D, Barthe Y, Pol S, Cacoub P, Zoulim F, Piroth L.

J Hepatol. 2014 Oct;61(4):761-9. doi: 10.1016/j.jhep.2014.05.030. Epub 2014 Jun 2.

PMID:
24882048
9.

[Treatment of hepatitis C infection. A revolution should not hide another].

Sogni P.

Presse Med. 2014 Apr;43(4 Pt 1):339-40. doi: 10.1016/j.lpm.2013.12.009. Epub 2014 Mar 21. French. No abstract available.

PMID:
24661837
10.

Oesophageal capsule endoscopy versus oesophago-gastroduodenoscopy for the diagnosis of recurrent varices: a prospective multicentre study.

Laurain A, de Leusse A, Gincul R, Vanbiervliet G, Bramli S, Heyries L, Martane G, Amrani N, Serraj I, Saurin JC, Borentain P, Filoche B, Duburque C, Gaudric M, Sogni P, Dumortier J.

Dig Liver Dis. 2014 Jun;46(6):535-40. doi: 10.1016/j.dld.2014.02.002. Epub 2014 Mar 13.

PMID:
24631032
11.

Impact of HCV treatment and depressive symptoms on adherence to HAART among HIV-HCV-coinfected patients: results from the ANRS-CO13-HEPAVIH cohort.

Roux P, Lions C, Cohen J, Winnock M, Salmon-Céron D, Bani-Sadr F, Sogni P, Spire B, Dabis F, Carrieri MP; ANRS-CO13-HEPAVIH Study Group.

Antivir Ther. 2014;19(2):171-8. doi: 10.3851/IMP2699. Epub 2013 Oct 28.

PMID:
24166726
12.

[Prognosis assessment of alcoholic liver disease: how and why?].

Trabut JB, Thépot V, Terris B, Sogni P, Nalpas B, Pol S.

Presse Med. 2014 Feb;43(2):124-34. doi: 10.1016/j.lpm.2013.04.016. Epub 2013 Oct 17. Review. French.

PMID:
24140195
13.

Successful treatment of l-asparaginase-induced severe acute hepatotoxicity using mitochondrial cofactors.

Al-Nawakil C, Willems L, Mauprivez C, Laffy B, Benm'rad M, Tamburini J, Fontaine H, Sogni P, Terris B, Bouscary D, Moachon L.

Leuk Lymphoma. 2014 Jul;55(7):1670-4. doi: 10.3109/10428194.2013.845886. Epub 2013 Nov 14. No abstract available.

PMID:
24090500
14.

Association between elevated coffee consumption and daily chocolate intake with normal liver enzymes in HIV-HCV infected individuals: results from the ANRS CO13 HEPAVIH cohort study.

Carrieri MP, Lions C, Sogni P, Winnock M, Roux P, Mora M, Bonnard P, Salmon D, Dabis F, Spire B; ANRS CO13 HEPAVIH Study Group.

J Hepatol. 2014 Jan;60(1):46-53. doi: 10.1016/j.jhep.2013.08.014. Epub 2013 Aug 24.

PMID:
23978720
15.

Rapid progression of antiviral treatments of chronic hepatitis C virus infection.

Pol S, Corouge M, Mallet V, Sogni P.

Minerva Gastroenterol Dietol. 2013 Jun;59(2):161-72.

PMID:
23831907
16.

Oral antiviral therapies for chronic hepatitis C infection.

Pol S, Corouge M, Sogni P.

Ther Adv Infect Dis. 2013 Jun;1(3):107-16. doi: 10.1177/2049936113488359. Review.

17.

Prevalence and risk factors for adenomas in the ileal pouch and the afferent loop after restorative proctocolectomy for patients with familial adenomatous polyposis.

Pommaret E, Vienne A, Lefevre JH, Sogni P, Florent C, Desaint B, Parc Y.

Surg Endosc. 2013 Oct;27(10):3816-22. doi: 10.1007/s00464-013-2980-x. Epub 2013 May 1.

PMID:
23636532
18.

[Severe cholestatic hepatitis revealing a DRESS syndrome].

Droz N, Thiebaut M, Terrier B, Bérézné A, Sogni P, Beuvon F, Guillevin L, Mouthon L.

Rev Med Interne. 2013 Oct;34(10):645-8. doi: 10.1016/j.revmed.2013.02.034. Epub 2013 Mar 26. French.

PMID:
23541141
19.

Management of hepatitis C virus infection in heavy drinkers.

Costentin CE, Trabut JB, Mallet V, Darbeda S, Thépot V, Nalpas B, Badin de Montjoye B, Lavielle B, Vallet-Pichard A, Sogni P, Pol S.

Alcohol Alcohol. 2013 May-Jun;48(3):337-42. doi: 10.1093/alcalc/agt020. Epub 2013 Mar 21.

20.

HIV-1 tropism and liver fibrosis in HIV-HCV co-infected patients.

Abravanel F, Raymond S, Pambrun E, Winnock M, Bonnard P, Sogni P, Trimoulet P, Dabis F, Salmon-Ceron D, Izopet J; ANRS CO13 HEPAVIH Study Group.

PLoS One. 2012;7(11):e50289. doi: 10.1371/journal.pone.0050289. Epub 2012 Nov 30.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk